Social sciences, risks and synthetic biology: A review of the literature

  • Arturo Vallejos-Romero University of La Frontera
  • César Cisternas Irarrazabal University of La Frontera
  • Ignacio Rodríguez University of La Frontera
  • Minerva Cordovés-Sánchez University of La Frontera
  • Patricio Padilla University of La Frontera
Keywords: Synthetic Biology, Risks, Controversies, Regulation, Governance


The article presents a review of the research social science on the risks related to synthetic biology, identifying the main lines of research, their problems and the most relevant challenges, which their own researchers and promoters have described as being of high importance and incidence in the profound social consequences it could have. The review covers 50 articles indexed in Web of Science (WoS) and SCOPUS, published between 2009 and April 2020. The work identified four areas of research on the risks of synthetic biology: risks, regulation, governance, and controversies, recognizing the challenges and opportunities in each of them.


Download data is not yet available.


Aghaei Chadegani, A.; Salehi, H., Md Yunus, M. M.; Farhadi, H.; Fooladi, M.; Farhadi, M.; Ale Ebrahim, N. (2013). A comparison between two main academic literature collections: Web of science and scopus databases. Asian Social Science, 9 (5), 18–26.
Ahteensuu, M. (2017). Synthetic Biology, Genome Editing, and the Risk of Bioterrorism. Science and Engineering Ethics, 23 (6), 1541–1561.
Akin, H.; Rose, K. M.; Scheufele, D. A.; Simis-Wilkinson, M.; Brossard, D.; Xenos, M. A.; Corley, E. A. (2017). Mapping the landscape of public attitudes on synthetic biology. BioScience, 67 (3), 290–300.
Ancillotti, M.; Rerimassie, V.; Seitz, S. B.; Steurer, W. (2016). An Update of Public Perceptions of Synthetic Biology: Still Undecided? NanoEthics, 10 (3), 309–325.
Bauer, A.; Bogner, A. (2020). Let’s (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues. Public Understanding of Science, 29 (5), 492–507.
Bogner, A.; Torgersen, H. (2015). Different ways of problematising biotechnology – and what it means for technology governance. Public Understanding of Science, 24 (5), 516–532.
Cummings, C. L.; Kuzma, J. (2017). Societal Risk Evaluation Scheme (SRES): Scenario-based multi-criteria evaluation of synthetic biology applications. PLoS ONE, 12 (1), 1–24.
Delborne, J. A.; Kokotovich, A. E.; Lunshof, J. E. (2020). Social license and synthetic biology: the trouble with mining terms. Journal of Responsible Innovation, 0 (0), 1–18.
Di Paola, L.; Giuliani, A. (2018). Multiscale synthetic biology: from molecules to ecosystems. En Piemonte, V.; Basile, A.; Ito, T.; Marrelli, L. (Eds.), Biomedical engineering challenges: a chemical engineering insight (pp. 97-117) Chichister: Wiley Blackwell.
Diéguez, A. (2017). Transhumanismo. La búsqueda tecnológica del mejoramiento humano. Herder.
Diéguez, A. (2020). Edición genética en humanos y la necesaria pregunta por los fines. Encuentros En La Biología, 12 (170), 11–15.
Ditlevsen, K.; Glerup, C.; Sandøe, P.; Lassen, J. (2020). Synthetic livestock vaccines as risky interference with nature? Lay and expert arguments and understandings of “naturalness.” Public Understanding of Science, 29 (3), 289–305.
Douglas, C. M. W.; Stemerding, D. (2014). Challenges for the European governance of synthetic biology for human health. Life Sciences, Society and Policy, 10 (1), 1–18.
Faunce, T. A. (2011). Will international trade law inhibit or promote global artificial photosynthesis? Asian Journal of WTO and International Health Law and Policy, 6 (2), 313–347.
Ferry, L. (2017). La revolución transhumanista. madrid: Alianza.
Forsberg, E. M.; Ribeiro, B.; Heyen, N. B.; Nielsen, R. Ø.; Thorstensen, E.; de Bakker, E.; Klüver, L.; Reiss, T.; Beekman, V.; Millar, K. (2016). Integrated assessment of emerging science and technologies as creating learning processes among assessment communities. Life Sciences, Society and Policy, 12 (1).
Funk, M.; Steizinger, J.; Falkner, D.; Eichinger, T. (2019). From Buzz to Burst—Critical Remarks on the Term ‘Life’ and Its Ethical Implications in Synthetic Biology. NanoEthics, 13 (3), 173–198.
Greer, S. L.; Trump, B. (2019). Regulation and regime: the comparative politics of adaptive regulation in synthetic biology. Policy Sciences, 52 (4), 505–524.
Gronvall, G. (2018). The security implications of synthetic biology. Survival, 60 (4), 165–180.
Gschmeidler, B.; Seiringer, A. (2012). “knight in shining armour” or “frankenstein’s creation”? the coverage of synthetic biology in German-language media. Public Understanding of Science, 21 (2), 163–173.
Hagen, K. (2016). Science Policy and Concomitant Research in Synthetic Biology—Some Critical Thoughts. NanoEthics, 10 (2), 201–213.
Hilgartner, S. (2012). Novel constitutions? New regimes of openness in synthetic biology. BioSocieties, 7 (2), 188–207.
Holm, S. (2019). Deciding in the Dark: The Precautionary Principle and the Regulation of Synthetic Biology. Ethics, Policy and Environment, 22 (1), 61–71.
Ineichen, C., Biller-Andorno, N.; Deplazes-Zemp, A. (2017). Image of synthetic biology and nanotechnology: A survey among university students. Frontiers in Genetics, 8 (SEP), 1–17.
Katz, L.; Chen, Y. Y.; Gonzalez, R.; Peterson, T. C.; Zhao, H.; Baltz, R. H. (2018). Synthetic biology advances and applications in the biotechnology industry: a perspective. Journal of Industrial Microbiology and Biotechnology, 45 (7), 449–461.
Keshava, R.; Mitra, R.; Gope, M.; Gope, R. (2018). Synthetic biology: overview and applications. En Barh, D.; Azevedo, V. (Eds.), Omics technologies and bio-engineering. Towards improving quality of life (pp. 63–93). Cambridge: Academic Press.
König, H.; Frank, D.; Heil, R.; Coenen, C. (2016). Synthetic biology’s multiple dimensions of benefits and risks: Implications for governance and policies. En Boldt, J. (Ed.), Synthetic Biology (pp. 217–232). Wiesbaden: Springer Berlin Heidelberg.
Kuiken, T.; Dana, G.; Oye, K.; Rejeski, D. (2014). Shaping ecological risk research for synthetic biology. Journal of Environmental Studies and Sciences, 4 (3), 191–199.
Kuzma, J.; Tanji, T. (2010). Unpackaging synthetic biology: Identification of oversight policy problems and options. Regulation and Governance, 4 (1), 92–112.
Lai, H. E.; Canavan, C.; Cameron, L.; Moore, S.; Danchenko, M.; Kuiken, T.; Sekeyová, Z.; Freemont, P. S. (2019). Synthetic Biology and the United Nations. Trends in Biotechnology, 37 (11), 1146–1151.
Lentzos, F. (2009). Synthetic Biology in the Social Context: The UK Debate to Date. BioSocieties, 4 (2–3), 303–315.
Luhmann, N. (1992). Sociología del riesgo. México DF: Universidad Iberoamericana y Universidad de Guadalajara.
Mali, F.; Kramberger, A. (2014). Recent challenges in the social regulation of new emerging technologies: The case of synthetic biology franc Mali, Anton kramberger. Teorija in Praksa, 51 (5), 850–865.
Mandel, G. N.; Marchant, G. E. (2014). The living regulatory challenges of synthetic biology. Iowa Law Review, 100 (1), 155–200.
Marris, C. (2015). The Construction of Imaginaries of the Public as a Threat to Synthetic Biology. Science as Culture, 24 (1), 83–98.
Marris, C.; Calvert, J. (2020). Science and Technology Studies in Policy: The UK Synthetic Biology Roadmap. Science Technology and Human Values, 45 (1), 34–61.
Marris, C.; Jefferson, C.; Lentzos, F. (2014). Negotiating the dynamics of uncomfortable knowledge: The case of dual use and synthetic biology. BioSocieties, 9 (4), 393–420.
Maurer, S. M.; Von Engelhardt, S. (2013). Industry self-governance: A new way to manage dangerous technologies. Bulletin of the Atomic Scientists, 69 (3), 53–62.
Meyer, M. (2013). Assembling, governing, and debating an emerging science: The rise of synthetic biology in France. BioScience, 63 (5), 373–379.
Meyer, M. (2017). “Participating means accepting”: debating and contesting synthetic biology. New Genetics and Society, 36 (2), 118–136.
Miller, C. A. (2015). Modeling risk in complex bioeconomies. Journal of Responsible Innovation, 2 (1), 124–127.
Mukunda, G.; Oye, K. A.; Mohr, S. C. (2009). What rough beast? Synthetic biology, uncertainty, and the future of biosecurity. Politics and the Life Sciences, 28 (2), 2–26.
Nesbeth, D. (2016). Introduction. En Nesbeth, D. Synthetic Biology Handbook (pp. ix–xiv). New Wales: CRC Press.
Nordberg, A.; Minssen, T.; Holm, S.; Horst, M.; Mortensen, K.; Møller, B. L. (2018). Cutting edges and weaving threads in the gene editing (ya{cyrillic})evolution: Reconciling scientific progress with legal, ethical, and social concerns. Journal of Law and the Biosciences, 5 (1), 35–83.
Oliver, A. (2018). Behavioral Economics and the Public Acceptance of Synthetic Biology. Hastings Center Report, 48 (February), S50–S55.
Pauwels, E. (2012). A reflection on the notion of cohabitation within and beyond the walls of life sciences. International Journal of Social Ecology and Sustainable Development, 3 (2), 1–10.
Pei, L.; Gaisser, S.; Schmidt, M. (2012). Synthetic biology in the view of european public funding organisations. Public Understanding of Science, 21 (2), 149–162.
Rabitz, F. (2019). Institutional Drift in International Biotechnology Regulation. Global Policy, 10 (2), 227–237.
Rager-Zisman, B. (2012). Ethical and regulatory challenges posed by synthetic biology. Perspectives in Biology and Medicine, 55 (4), 590–607.
Rerimassie, V. (2016). Exploring Political Views on Synthetic Biology in the Netherlands. NanoEthics, 10 (3), 289–308.
Ribeiro, B.; Shapira, P. (2019). Anticipating governance challenges in synthetic biology: Insights from biosynthetic menthol. Technological Forecasting and Social Change, 139 (May 2018), 311–320.
Rose, K. M.; Howell, E. L.; Scheufele, D. A.; Brossard, D.; Xenos, M. A.; Shapira, P.; Youtie, J.; Kwon, S. (2018). The values of synthetic biology: Researcher views of their field and participation in public engagement. BioScience, 68 (10), 782–791.
Shapira, P.; Youtie, J.; Li, Y. (2015). Social science contributions compared in synthetic biology and nanotechnology. Journal of Responsible Innovation, 2 (1), 143–148.
Sinden, A. (2018). Lessons from Environmental Regulation. Hastings Center Report, 48 (February), S56–S64.
Stemerding, D.; Betten, W.; Rerimassie, V.; Robaey, Z.; Kupper, F. (2019). Future making and responsible governance of innovation in synthetic biology. Futures, 109, 213–226.
Su, L. Y. F.; Scheufele, D. A.; Brossard, D.; Xenos, M. A. (2020). Political and personality predispositions and topical contexts matter: Effects of uncivil comments on science news engagement intentions. New Media and Society.
Tait, J.; Wield, D. (2019). Policy support for disruptive innovation in the life sciences. Technology Analysis and Strategic Management, 0 (0), 1–13.
Torgersen, H.; Hampel, J. (2012). Calling controversy: Assessing synthetic biology’s conflict potential. Public Understanding of Science, 21 (2), 134–148.
Torgersen, H.; Schmidt, M. (2013). Frames and comparators: How might a debate on synthetic biology evolve? Futures, 48, 44–54.
Trump, B. D.; Cummings, C.; Kuzma, J.; Linkov, I. (2018). A decision analytic model to guide early-stage government regulatory action: Applications for synthetic biology. Regulation and Governance, 12 (1), 88–100.
Trump, B. D. (2017). Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore. Health Policy, 121 (11), 1139–1146.
Trump, B. D.; Cegan, J.; Wells, E.; Poinsatte-Jones, K.; Rycroft, T.; Warner, C.; Martin, D.; Perkins, E.; Wood, M. D.; Linkov, I. (2019). Co-evolution of physical and social sciences in synthetic biology. Critical Reviews in Biotechnology, 39 (3), 351–365.
Trump, B., Cummings, C., Galaitsi, S.E., Kuzma, J. and Linkov, I. (2020). Synthetic Biology: Perspectives on Risk Analysis, Governance, Communication, and ELSI. In Trump, B., Cummings, C., Kuzma, J. and Linkov. I. (Eds), Synthetic Biology 2020. Frontiers in Risk Analysis and Governance (pp 1-18). Swirzerland: Springer.
van Doren, D.; Heyen, N. B. (2014). Synthetic biology: Too early for assessments? A review of synthetic biology assessments in Germany. Science and Public Policy, 41 (3), 272–282.
van Eck, N. J.; Waltman, L. (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84 (2), 523–538.
Wallach, W.; Saner, M.; Marchant, G. (2018). Beyond Cost-Benefit Analysis in the Governance of Synthetic Biology. Hastings Center Report, 48 (February), S70–S77.
Walsh, P. F. (2020). Improving ‘Five Eyes’ health security intelligence capabilities: leadership and governance challenges. Intelligence and National Security, 00 (00), 1–17.
Wiek, A.; Guston, D.; Frow, E.; Calvert, J. (2012). Sustainability and anticipatory governance in synthetic biology. International Journal of Social Ecology and Sustainable Development, 3 (2), 25–38.